New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 25, 2014
07:36 EDTBINDBIND Therapeutics reports Q4 EPS (50c), consensus (41c)
Reports Q4 revenue $2.07M, consensus $3.24M. Reports research and development expenses totaled $7.4M for Q4.
News For BIND From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 14, 2014
11:23 EDTBINDBIND Therapeutics and The Conference Forum hold a conference
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use